Additionally, our research underscores the importance of additional work to elucidate the biological roles of CINC-1, CD95, and fractalkine in PAD pathogenesis, offering insights for developing personalized diagnostic and therapeutic strategies. This evidence concerns the gene CX3CL1 and peripheral arterial disease.